日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessment of breast-feeding and weaning practices of under-fives and their associated co-morbidities in urban and rural areas of Ahmedabad City, Gujarat, India

对印度古吉拉特邦艾哈迈达巴德市城乡地区五岁以下儿童母乳喂养和断奶做法及其相关并发症的评估

期刊:Journal of Family Medicine and Primary Care
影响因子:1
doi:10.4103/jfmpc.jfmpc_1203_23
Rastogi, Swarna; Lala, M K
发表日期：2024
文献求助 收藏

Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial

比较奥利万星前置负荷给药方案与每日给药方案的疗效和安全性：SIMPLIFI试验分析

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00029-11
Dunbar, Lala M; Milata, Joe; McClure, Ty; Wasilewski, Margaret M
MPL
LIF
发表日期：2011
文献求助 收藏

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

特拉万星治疗复杂性皮肤及皮肤结构感染（cSSSI）的综述

期刊:Therapeutics and Clinical Risk Management
影响因子:2.2
doi:10.2147/tcrm.s1843
Dunbar, Lala M; Tang, Derek M; Manausa, Robert M
炎症/感染
发表日期：2008
文献求助 收藏

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study

特拉万星与标准疗法治疗革兰氏阳性菌引起的复杂性皮肤及皮肤结构感染的疗效比较：FAST 2 研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.50.3.862-867.2006
Stryjewski, Martin E; Chu, Vivian H; O'Riordan, William D; Warren, Brian L; Dunbar, Lala M; Young, David M; Vallée, Marc; Fowler, Vance G Jr; Morganroth, Joel; Barriere, Steven L; Kitt, Michael M; Corey, G Ralph
FAS
炎症/感染
发表日期：2006
文献求助 收藏

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

泰利霉素 800 mg 每日一次，疗程 7 天治疗社区获得性肺炎的疗效和安全性：一项开放标签、多中心研究

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/1471-2334-5-43
Fogarty, Charles M; Patel, Tushar C; Dunbar, Lala M; Leroy, Bruno P
肺炎
发表日期：2005
文献求助 收藏